tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Carl Byrnes, 76 are a BUY (89.41%), 7 are a HOLD (8.24%), 2 are a SELL (2.35%).
Analyst Carl Byrnes, currently employed at NORTHLAND CAPITAL MARKETS, carries an average stock price target met ratio of 22.86% that have a potential upside of 23.05% achieved within 223 days.
Carl Byrnes’s has documented 164 price targets and ratings displayed on 21 stocks. The coverage is on Healthcare, Consumer Defensive, Energy sectors.
Most recent stock forecast was given on BWAY, Brainsway Ltd at 11-Nov-2025.
Analyst best performing recommendations are on ESPR (ESPERION THERAPEUTICS).
The best stock recommendation documented was for ESPR (ESPERION THERAPEUTICS) at 2/24/2020. The price target of $60 was fulfilled within 1 day with a profit of $2.86 (4.55%) receiving and performance score of 45.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Dec-2021
$5
5 months 18 days ago
(04-May-2026)
1/12 (8.33%)
$2.09 (71.82%)
205
Buy Since 11-Mar-2022
$3.16
$-0.01 (-0.32%)
$16
5 months 21 days ago
(01-May-2026)
1/8 (12.5%)
$0.05 (1.61%)
46
Sell Since 16-Mar-2026
$1.78
$-1.4 (-44.03%)
$2.5
7 months 6 days ago
(16-Mar-2026)
2/4 (50%)
$-0.91 (-33.83%)
29
Buy Since 11-Nov-2015
$5
$1.83 (57.73%)
$4
7 months 9 days ago
(13-Mar-2026)
2/13 (15.38%)
$2.56 (104.92%)
464
Buy Since 25-Nov-2025
$9
$5.82 (183.02%)
10 months 27 days ago
(25-Nov-2025)
0/1 (0%)
$5.31 (143.90%)
What Year was the first public recommendation made by Carl Byrnes?
